ECMO Support in Lung Transplantation

Madonna Lee; Daniel Mansour; Bryan A. Whitson

doi:10.1007/978-3-030-40679-0_87

ECMO Support in Lung Transplantation

Madonna Lee
, Daniel Mansour
, Bryan A. Whitson

School of Medicine

Ohio State University

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

In the field of lung transplantation, extracorporeal membrane oxygenation (ECMO) can be used in multiple phases of perioperative care including pre-operatively as a bridge to transplantation, intraoperative support, and post-operative support for delayed graft function. ECMO is safe for use in patients with end-stage lung disease who experience rapid clinical deterioration prior to lung transplantation [1]. At some institutions, ECMO has replaced cardiopulmonary bypass intraoperatively during transplantation [2, 3]. After implantation, ECMO has been employed as a management strategy to support early failing allografts in lung transplantation [4]. Indications, patient selection, technical considerations, and outcomes for ECMO support in lung transplantation are described in this chapter.

Original language	English
Title of host publication	Thoracic Surgery
Subtitle of host publication	Cervical, Thoracic and Abdominal Approaches
Publisher	Springer International Publishing
Pages	987-993
Number of pages	7
ISBN (Electronic)	9783030406790
ISBN (Print)	9783030406783
DOIs	https://doi.org/10.1007/978-3-030-40679-0_87
State	Published - 1 Jan 2020

Keywords

ECMO
Extracorporeal membrane oxygenation
Lung transplantation

Access to Document

10.1007/978-3-030-40679-0_87

Cite this

@inbook{e0eb99d723fc468b88cf63fd860fce0b,

title = "ECMO Support in Lung Transplantation",

abstract = "In the field of lung transplantation, extracorporeal membrane oxygenation (ECMO) can be used in multiple phases of perioperative care including pre-operatively as a bridge to transplantation, intraoperative support, and post-operative support for delayed graft function. ECMO is safe for use in patients with end-stage lung disease who experience rapid clinical deterioration prior to lung transplantation [1]. At some institutions, ECMO has replaced cardiopulmonary bypass intraoperatively during transplantation [2, 3]. After implantation, ECMO has been employed as a management strategy to support early failing allografts in lung transplantation [4]. Indications, patient selection, technical considerations, and outcomes for ECMO support in lung transplantation are described in this chapter.",

keywords = "ECMO, Extracorporeal membrane oxygenation, Lung transplantation",

author = "Madonna Lee and Daniel Mansour and Whitson, \{Bryan A.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2020.",

year = "2020",

month = jan,

day = "1",

doi = "10.1007/978-3-030-40679-0\_87",

language = "English",

isbn = "9783030406783",

pages = "987--993",

booktitle = "Thoracic Surgery",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - ECMO Support in Lung Transplantation

AU - Lee, Madonna

AU - Mansour, Daniel

AU - Whitson, Bryan A.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2020.

PY - 2020/1/1

Y1 - 2020/1/1

N2 - In the field of lung transplantation, extracorporeal membrane oxygenation (ECMO) can be used in multiple phases of perioperative care including pre-operatively as a bridge to transplantation, intraoperative support, and post-operative support for delayed graft function. ECMO is safe for use in patients with end-stage lung disease who experience rapid clinical deterioration prior to lung transplantation [1]. At some institutions, ECMO has replaced cardiopulmonary bypass intraoperatively during transplantation [2, 3]. After implantation, ECMO has been employed as a management strategy to support early failing allografts in lung transplantation [4]. Indications, patient selection, technical considerations, and outcomes for ECMO support in lung transplantation are described in this chapter.

AB - In the field of lung transplantation, extracorporeal membrane oxygenation (ECMO) can be used in multiple phases of perioperative care including pre-operatively as a bridge to transplantation, intraoperative support, and post-operative support for delayed graft function. ECMO is safe for use in patients with end-stage lung disease who experience rapid clinical deterioration prior to lung transplantation [1]. At some institutions, ECMO has replaced cardiopulmonary bypass intraoperatively during transplantation [2, 3]. After implantation, ECMO has been employed as a management strategy to support early failing allografts in lung transplantation [4]. Indications, patient selection, technical considerations, and outcomes for ECMO support in lung transplantation are described in this chapter.

KW - ECMO

KW - Extracorporeal membrane oxygenation

KW - Lung transplantation

UR - https://www.scopus.com/pages/publications/85151211488

U2 - 10.1007/978-3-030-40679-0_87

DO - 10.1007/978-3-030-40679-0_87

M3 - Chapter

AN - SCOPUS:85151211488

SN - 9783030406783

SP - 987

EP - 993

BT - Thoracic Surgery

PB - Springer International Publishing

ER -

ECMO Support in Lung Transplantation

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this